This secondary analysis of data from the Dual Antiplatelet Therapy (DAPT) trial describes development of a risk prediction tool to identify benefits and harms of continuing thienopyridine therapy after an initial year of treatment following percutaneous coronary intervention.
This randomized clinical trial investigated whether fully covered, self-expandable metallic stents are noninferior to plastic stents for achieving stricture resolution in patients with benign biliary strictures and a bile duct diameter ≥6 mm in whom the covered metallic stent would not overlap the cystic duct.
This randomized trial assesses the long-term clinical outcomes with intravascular ultrasound–guided drug-eluting stent implantation vs those with angiography-guided implantation in Korean patients with long coronary lesions.
This systematic review summarizes the pathophysiology of acute brain ischemia and infarction and available reperfusion treatments.
To determine risk factors for adverse cardiac events in patients undergoing noncardiac surgery after coronary stent implantation, Hawn and coauthors conducted a national, retrospective cohort study of 41 989 operations occurring within 2 years of stent placement. In an Editorial, Brilakis and Banerjee discuss the approach clinicians can take with patients who need surgery after receiving stents.
In a review of the literature on optimal medical therapy after percutaneous coronary intervention
(PCI), Brilakis and coauthors determined that dual antiplatelet therapy remains the standard of
care, with adjustments as needed for patients at high risk for bleeding and those who have coronary